These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 9310450)

  • 1. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
    Klapstein GJ; Colmers WF
    J Neurophysiol; 1997 Sep; 78(3):1651-61. PubMed ID: 9310450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.
    Ho MW; Beck-Sickinger AG; Colmers WF
    J Neurophysiol; 2000 Feb; 83(2):723-34. PubMed ID: 10669488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
    El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
    Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
    Bijak M
    Neurosci Lett; 1999 Jun; 268(3):115-8. PubMed ID: 10406018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus.
    McQuiston AR; Colmers WF
    J Neurophysiol; 1996 Nov; 76(5):3159-68. PubMed ID: 8930263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors.
    Baraban SC
    Epilepsia; 2002; 43 Suppl 5():9-13. PubMed ID: 12121287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro.
    Klapstein GJ; Colmers WF
    Hippocampus; 1993 Jan; 3(1):103-11. PubMed ID: 8395947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal inhibitory neuron activity in the elevated potassium model of epilepsy.
    McBain CJ
    J Neurophysiol; 1994 Dec; 72(6):2853-63. PubMed ID: 7897494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ictal epileptiform activity in the CA3 region of hippocampal slices produced by pilocarpine.
    Rutecki PA; Yang Y
    J Neurophysiol; 1998 Jun; 79(6):3019-29. PubMed ID: 9636105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
    Monnet FP; Fournier A; Debonnel G; de Montigny C
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y suppresses epileptiform discharges by regulating AMPA receptor GluR2 subunit in rat hippocampal neurons.
    Bu W; Zhao WQ; Li WL; Dong CZ; Zhang Z; Li QJ
    Mol Med Rep; 2017 Jul; 16(1):387-395. PubMed ID: 28498410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal inhibitory neuron activity in the elevated potassium model of epilepsy.
    McBain CJ
    J Neurophysiol; 1995 Feb; 73(2):2853-63. PubMed ID: 7760109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic GABA(A) activation inhibits AMPA-kainate receptor-mediated bursting in the newborn (P0-P2) rat hippocampus.
    Lamsa K; Palva JM; Ruusuvuori E; Kaila K; Taira T
    J Neurophysiol; 2000 Jan; 83(1):359-66. PubMed ID: 10634879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
    Browning KN; Travagli RA
    J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced NMDA conductance can account for epileptiform activity induced by low Mg2+ in the rat hippocampal slice.
    Traub RD; Jefferys JG; Whittington MA
    J Physiol; 1994 Aug; 478 Pt 3(Pt 3):379-93. PubMed ID: 7965853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study.
    Smiałowska M; Bijak M; Sopala M; Tokarski K
    Neuropeptides; 1996 Feb; 30(1):7-12. PubMed ID: 8868293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.